United States / State guide

Peptides in California: verify the seller class first.

A clean California market brief for comparing licensed care, pharmacy status, research listings, and the real landed cost.

US research listing snapshotCompare 7 current BPC-157 listingsExact-size public listings kept separate from clinics and pharmacies.
Market brief

What changes in California.

Search results often blur clinics, pharmacies, wellness marketing, and chemical suppliers. This guide keeps those seller classes separate.

  • California maintains public license verification for pharmacies and pharmacists.
  • The federal FDA framework still applies to drug approval and many compounding questions.
  • Research-only materials are shown in a separate table and are not presented for human use.
Verification route

Know which record answers which question.

Local checklist

Three checks before any comparison.

Use this checklist to verify the local product, seller, and supply records before comparing price or availability.

01

Verify the license

Use California’s pharmacy lookup for any seller presenting a product as a prescription medicine.

02

Inspect evidence

Record who ran the test, the method, batch identifier, and date. Treat an unmatched COA as missing evidence.

03

Price the basket

Compare product, shipping, consultation, and recurring fees together instead of relying on a headline price.

Direct answers

What this guide can - and cannot - answer.

Each answer is tied to the local records below so you can see what is confirmed, what remains unknown, and where to recheck it. Open the primary sources ↓

01

Can every peptide offer be treated as legal to buy in California?

No blanket answer is supportable. Use California’s pharmacy lookup for any seller presenting a product as a prescription medicine. In California, begin with License verification from California State Board of Pharmacy; the product, seller, and supply route still need to resolve to the same current record.

02

Does this page name the best place to buy peptides in California?

No. In California, the 78 us listings / 20 boards shown here are national laboratory-research catalog observations ordered by availability and public list price at a matched nominal size. They do not rank local pharmacies, clinics, prescription access, medical suitability, safety, or quality.

03

Which official records should I check first in California?

For California, start with License verification from California State Board of Pharmacy, then open Peptide compounding safety risks from U.S. FDA. The records answer separate questions, so confirm each current entry instead of treating one match as proof of the seller, product, and route together.

Compound and state routes

Tracked peptide names in California.

Each answer preserves the compound’s research, clinical, or medicine identity and then points to the official California verification route. A shared name or state license is not a blanket product, seller, legal, or availability finding.

01FDA-reviewed unapproved peptide identity

KPV in California

KPV in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
02US research-market identity

BPC-157 in California

BPC-157 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
03US research-market identity

TB-500 in California

TB-500 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
04US research-market identity

GHK-Cu in California

GHK-Cu in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
05US research-market identity

Semax in California

Semax in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
06US research-market identity

Melanotan II in California

Melanotan II in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
07US research-market identity

MOTS-c in California

MOTS-c in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin in California

Tesamorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 in California

AOD-9604 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
10US research-market identity

Ipamorelin in California

Ipamorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
11US research-market identity

Selank in California

Selank in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide in California

PT-141 / Bremelanotide in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
13US research-market identity

CJC-1295 no DAC in California

CJC-1295 no DAC in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
14US research-market identity

CJC-1295 DAC in California

CJC-1295 DAC in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
15Investigational clinical program

Retatrutide in California

Retatrutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
16China-approved medicine and active clinical program

Mazdutide in California

Mazdutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
17China-approved medicine and active development program

Ecnoglutide in California

Ecnoglutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
18Investigational clinical program

Enicepatide in California

Enicepatide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
19Investigational clinical program

Eloralintide in California

Eloralintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
20Investigational clinical program

Cagrilintide in California

Cagrilintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
21Investigational clinical program

Petrelintide in California

Petrelintide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
22Investigational clinical program

CagriSema in California

CagriSema in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
23Investigational clinical program

MariTide in California

MariTide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
24Investigational clinical program

Survodutide in California

Survodutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
25Investigational clinical program

VK2735 in California

VK2735 in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
26Investigational clinical program

Pemvidutide in California

Pemvidutide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
27Investigational clinical program

Amycretin / Zenagamtide in California

Amycretin / Zenagamtide in California refers to an investigational clinical program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
28US FDA medicine reference

Tirzepatide in California

Tirzepatide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo in California

Orforglipron / Foundayo in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
30Product-specific approved medicine records in multiple jurisdictions

Semaglutide in California

Semaglutide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide in California

DSIP / Emideltide in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
32US research-market identity

IGF-1 LR3 in California

IGF-1 LR3 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
33US research-market identity

Kisspeptin-10 / KP-10 in California

Kisspeptin-10 / KP-10 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
34US research-market identity separated from SCENESSE

Melanotan I in California

Melanotan I in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
35US research-market non-peptide coenzyme identity

NAD+ in California

NAD+ in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
36US research-market identity with a withdrawn historical medicine record

Sermorelin in California

Sermorelin in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 in California

Thymosin Alpha-1 in California begins with a US research-market identity, not a finding that a same-name product is approved, available, lawfully supplied, or appropriate for use. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR in California

EGRIFTA WR in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
39Product-specific FDA and EU medicine records

Liraglutide in California

Liraglutide in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
40Product-specific FDA and EU medicine records

SCENESSE in California

SCENESSE in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
41Product-specific FDA-approved US medicine record

VYLEESI in California

VYLEESI in California begins with a US FDA medicine identity. Approval belongs to exact applications, products, presentations, labeled uses, and regulated supply routes, not every listing that shares the ingredient name. For a pharmacy, prescription, or seller claim involving California, open License verification from California State Board of Pharmacy and match the legal name, address, current license status, product category, and claimed supply route. A state license record does not authenticate a different product or transfer the status of one evidence lane to another.

Official state recordLicense verificationCalifornia State Board of Pharmacy
Research listing snapshot

US public prices, kept in their category.

These listings are for laboratory research materials. They are not local clinics, pharmacies, or approved products for human use.

7/7 rows shown
Commercial-link disclosure: we may earn a commission after a click. Placement does not change price rank. Seller testing claims are labeled, not treated as our own verification.
Current board5 of 7 in stockAvailable list range $40.00–$92.00

Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.

Compare two lowest in-stock rows
Custom comparisonChoose two rows for a landed-cost check.Select any two seller rows. The calculator carries over list price and nominal milligrams, then lets you add shipping and mandatory fees.
0 / 2 selected
Select 2 more rows
Latest source recheck7/7current price and availability signals confirmed

Checked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.

Open source-check ledger
BPC-157 supplier prices, price per milligram, public evidence access, shipping claims, and source links
Price rank / supplier10 mg pricePrice / mgPublic evidenceShipping claimOpen listing
01Pure Health PeptidesPrice and stock confirmed Jul 27In stock
$4.00Public lot COA libraryAccess: Public link · Seller claim · Jul 27, 2026Free shipping over $175; lower-order rate at checkout
02Purgo LabsCurrent public batch reportIn stock
$4.50Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026Live UPS rate; free UPS 3 Day Select over $250
03Pepta LabsFree US shipping claimedIn stock
$5.28COA on requestAccess: On request · Seller claim · Jul 23, 2026Free US shipping claimed
04Prime PeptidesPublic report linkedIn stock
$6.00Report displayedAccess: Public link · Seller claim · Jul 23, 2026$9.95 US; free over $150
05Biotech PeptidesPublic size-specific documentsIn stock
$9.20COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026Free USPS Priority over $200; lower-order rate not stated
06AminoCore ResearchPrice confirmed; stock not statedStatus not stated
$5.50COA includedAccess: Included with order · Seller claim · Jul 23, 2026Free shipping claimed
07Core PeptidesPrice shown; stock label absentStatus not stated
$9.70COA tab shownAccess: Public link · Seller claim · Jul 23, 2026Free over $200; lower-order rate at checkout
01

Pure Health Peptides

Price and stock confirmed Jul 27 · In stock
$40.00
Per mg
$4.00
Evidence
Public lot COA libraryPublic link
Shipping
Free shipping over $175; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
02

Purgo Labs

Current public batch report · In stock
$44.99
Per mg
$4.50
Evidence
Public batch reportsPublic link
Shipping
Live UPS rate; free UPS 3 Day Select over $250
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
03

Pepta Labs

Free US shipping claimed · In stock
$52.79
Per mg
$5.28
Evidence
COA on requestOn request
Shipping
Free US shipping claimed
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
05

Biotech Peptides

Public size-specific documents · In stock
$92.00
Per mg
$9.20
Evidence
COA, LC, and MS imagesPublic link
Shipping
Free USPS Priority over $200; lower-order rate not stated
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
07

Core Peptides

Price shown; stock label absent · Status not stated
$97.00
Per mg
$9.70
Evidence
COA tab shownPublic link
Shipping
Free over $200; lower-order rate at checkout
Source confirmedThe current public seller source returned the same exact-product price and a reliable availability signal. The dated base row remains a separate observation.
Audit record
Primary sources

Repeat the checks yourself.

Official sources are linked directly. Open them to confirm the current record; this page is a guide, not a substitute for the regulator.

Related guides